H5N1 Bird Flu in 2026: A Comprehensive Status Report on the US Outbreak

Introduction to the H5N1 Panzootic Landscape

The emergence, evolution, and subsequent global dissemination of the highly pathogenic avian influenza A virus subtype H5N1 represent one of the most complex ecological and public health challenges of the twenty-first century. Originating from the goose/Guangdong viral lineage first identified in commercial fowl in China in 1996, the virus has undergone decades of intricate genetic reassortment and geographic expansion.¹ The current global panzootic is primarily driven by the 2.3.4.4b clade, a highly adaptable lineage that was introduced to the North American continent in late 2021.² This introduction occurred primarily through the movement of migratory waterfowl navigating the trans-Atlantic and Pacific flyways, effectively seeding the virus into naive environmental and agricultural ecosystems across the United States.²

What began as an unprecedented epizootic event heavily affecting commercial poultry and wild avian species has rapidly transformed over the past several years into a multi-species crisis. This crisis is characterized by increasingly frequent viral spillovers into mammalian hosts, altering the fundamental understanding of avian influenza ecology.² By the early months of 2026, the epidemiological landscape of H5N1 in the United States had shifted dramatically. The pathogen is no longer strictly confined to avian reservoirs; it has established sustained, multi-state transmission networks within domestic dairy cattle, breached the species barrier to infect domestic swine, caused fatal neurological infections in domestic and marine mammals, and resulted in sporadic, sometimes fatal, human infections.³

The detection of the virus in over 1,000 dairy herds across at least 17 states, alongside 71 confirmed human cases since 2024, underscores a critical juncture in the evolutionary trajectory of the pathogen.⁷ The United States Department of Agriculture has classified the ongoing poultry outbreak as the largest and longest animal health disease incident in the history of the nation, severely eclipsing the previous record-breaking outbreak of 2014 to 2015.⁸ Concurrently, the Centers for Disease Control and Prevention maintains that the current public health risk to the general United States population remains categorized as low, as there is currently no epidemiological evidence to suggest sustained, human-to-human transmission.⁷

However, the continuous, widespread circulation of the virus in a highly diverse array of mammalian hosts provides an expansive ecological arena for genetic reassortment and progressive mammalian adaptation.⁹ The paradigm of highly pathogenic avian influenza has transitioned from an acute agricultural threat to a protracted, interdisciplinary One Health emergency.¹⁰ This comprehensive report provides an exhaustive analysis of the current status of the H5N1 outbreak in the United States as of February 2026, detailing the virological evolution, agricultural impact, mammalian spillover dynamics, and human epidemiological profiles associated with the virus.

Genomic Evolution and Molecular Adaptation

To understand the widespread dissemination of H5N1 across multiple species, it is necessary to examine the molecular architecture and evolutionary mechanisms of the influenza A virus. The viral genome consists of eight distinct segments of negative-sense single-stranded ribonucleic acid. This segmented genetic structure allows for a phenomenon known as antigenic shift, or genetic reassortment.¹² When two different influenza viruses simultaneously co-infect the same host cell, they can swap entire gene segments during the replication process to produce a novel viral progeny.¹² The evolutionary success of the current H5N1 clade 2.3.4.4b relies heavily on this mechanism, allowing it to continually reassort with endemic North American wild bird influenza viruses to generate multiple distinct, highly virulent genotypes.¹³

The Emergence of Genotype B3.13 in Dairy Cattle

The most consequential evolutionary development in the United States outbreak has been the emergence of the B3.13 genotype. First confirmed by the United States Department of Agriculture in March 2024 from unpasteurized clinical milk samples collected from sick cattle in Texas and Kansas, phylogenetic analysis indicated that the B3.13 genotype arose from a single introduction event from wild birds into a novel bovine host.¹⁴ This initial spillover was subsequently followed by widespread, sustained onward transmission within the dairy cattle population across the country.¹⁴

The sustained transmission of a highly pathogenic avian influenza virus in cattle was historically unprecedented and required specific genetic alterations. Molecular analysis of the B3.13 genotype reveals specific adaptations that facilitate this interspecies leap. Most notably, the virus acquired an amino acid substitution in the polymerase basic protein 2, specifically designated as the PB2 M631L mutation.¹⁵ The viral polymerase complex is the molecular machinery responsible for replicating the viral genome within the host cell. Avian influenza polymerases typically function poorly in mammalian cells due to differences in host cellular proteins, specifically the acidic leucine-rich nuclear phosphoprotein 32 family. Scientific investigations have demonstrated that the PB2 M631L mutation specifically enhances the ability of the viral polymerase to interact with bovine cellular proteins, particularly the bovine ANP32A protein.⁹

This single molecular alteration significantly boosted the replication efficiency of the virus in bovine mammary tissues and respiratory cells.⁹ Furthermore, laboratory analyses indicate that this mutation also enhances viral replication in primary human airway cultures, demonstrating that genetic adaptation to one mammalian species can inadvertently lower the biological barriers to infecting another.⁹ While B3.13 remains the predominant genotype responsible for the widespread dairy epizootic, continuous viral replication in cattle herds has allowed for the further accumulation of mutations. Sequencing has revealed changes in the polymerase acidic protein, such as the PA K497R substitution, which further optimizes the viral replication machinery for mammalian cellular environments.⁹

The D-Lineage Genotypes and Continuous Spillover

The evolutionary landscape of H5N1 is highly dynamic, and the B3.13 genotype is not the sole variant of concern. In early 2025, robust national surveillance efforts identified a new genotype, D1.1, causing isolated outbreaks in dairy cattle in Nevada and Arizona.¹⁸ Genomic sequencing confirmed that the D1.1 genotype represents a separate and distinct spillover event from wild birds into cattle, entirely independent of the B3.13 lineage.¹⁸ The D1.1 genotype is descended from the A3 genotype introduced to North America in 2022 and has widely circulated in wild birds and poultry.¹³ Its successful detection in cattle signifies that the barrier to bovine infection is lower than previously understood, and cattle populations are susceptible to multiple distinct lineages of avian influenza.¹⁸

Other notable variants within the D-lineage include the D1.2 genotype, which was identified in the first confirmed domestic swine infection in the United States in October 2024, and the D1.3 genotype, which caused a severe human infection in an Ohio commercial poultry worker in February 2025.¹³ The constant generation and successful spillover of these highly diverse genotypes highlight a robust viral ecosystem where continuous reassortment events are actively probing the immunological and molecular defenses of various mammalian hosts.

Table 1 summarizes the key viral genotypes driving the ongoing outbreak in the United States and their primary epidemiological significance.

Table 1: Key H5N1 Genotypes Identified in the United States (2024-2026)

Genotype	Primary Host Reservoir	Epidemiological Significance
B3.13	Dairy Cattle	Responsible for the vast majority of bovine infections. Characterized by the PB2 M631L mutation, enabling highly efficient viral replication in mammalian cells.14
D1.1	Poultry, Wild Birds, Dairy Cattle	A distinct spillover lineage detected in Nevada and Arizona cattle in 2025. This genotype was also associated with the first fatal human H5N1 case in Louisiana.13
D1.2	Poultry, Migratory Birds, Swine	Identified in the first confirmed domestic swine infection in Oregon (October 2024), highlighting the profound risk of viral reassortment in mixing vessel hosts.12
D1.3	Commercial Poultry	A reassortant wild bird lineage implicated in the severe illness and hospitalization of an Ohio commercial poultry worker in February 2025.13

The Bovine Epizootic: Dynamics of the Dairy Cattle Outbreak

The initial identification of highly pathogenic avian influenza in dairy cattle in the spring of 2024 began not with mass mortality, but with clinical observations of a sudden, unexplained decline in milk production.²⁰ Dairy farmers across several states noted that lactating cows produced thickened, discolored milk and exhibited signs of general lethargy, without complete certainty as to the underlying cause.²⁰ It was soon discovered that the virus exhibits a strong tissue tropism for the bovine mammary gland, leading to the shedding of extraordinarily high viral loads in raw, unpasteurized milk.²¹

Retrospective research analyzing retail milk samples from April and May of 2024 revealed that the virus was already highly prevalent before widespread federal reporting began. Viral ribonucleic acid was detected in 36 percent of retail milk samples tested across 13 states, including five states (Arkansas, Indiana, Minnesota, Missouri, and Oklahoma) that had not yet reported any official herd outbreaks at the time.²² Across the country, only 29 infected herds had been officially reported as of mid-April 2024, a figure grossly inconsistent with the high number of positive retail samples.²³ This finding strongly suggests that the initial spread of the virus among dairy herds was silent, highly rapid, and significantly underestimated by early symptom-based surveillance metrics.²²

Implementation of the National Milk Testing Strategy

To combat the widespread and often subclinical dissemination of the virus, the United States Department of Agriculture officially implemented the National Milk Testing Strategy in December 2024.¹⁸ This strategy fundamentally altered the national surveillance approach from reactive, symptom-based testing to proactive, systematic screening. The strategy utilizes a comprehensive five-stage roadmap designed to identify affected herds, monitor geographic trends through national processing plant silo testing, and facilitate the safe interstate movement of lactating cattle.²⁵

The progressive stages of the strategy operate as follows: Stage 1 involves the national monitoring of milk silos at dairy processing facilities to identify regional viral presence; Stage 2 involves working directly with states to establish bulk milk sampling programs at the farm level; and subsequent stages (such as Stage 3, where a state is assigned if at least one dairy herd is confirmed positive) guide states toward demonstrating an unaffected, virus-free status.²⁶ By January 2025, the National Milk Testing Strategy had successfully expanded to include 28 states, representing approximately 65 percent of the nation's total milk production.²⁷

Under this rigorous framework, raw milk samples collected from farm bulk tanks are continuously monitored. A positive detection triggers an immediate state-level epidemiological investigation.²⁶ The successful implementation of this strategy was instrumental in detecting the novel D1.1 genotype spillover in Nevada and Arizona in early 2025, demonstrating the immense utility of broad-scale environmental and product sampling in identifying novel disease introductions before they manifest as widespread clinical outbreaks.¹⁸

As of February 2026, the cumulative impact of the bovine epizootic remains immense, with over 1,000 dairy herds confirmed positive across more than 17 states.³ California emerged as one of the hardest-hit regions, reporting 759 confirmations and prompting the state's governor to announce a state of emergency in December 2024 to shore up agricultural response efforts.³ While the virus is generally not fatal to mature cattle, the high viral loads shed in raw milk present a profound environmental contamination risk to other species and a severe occupational hazard to dairy workers. It is important to note that the United States Food and Drug Administration maintains that the commercial milk supply remains entirely safe for human consumption, as standard pasteurization processes effectively inactivate the virus, and there have been no known illnesses from the consumption of aged raw milk cheese products.²⁹ However, the continued circulation in cattle provides the virus with millions of mammalian hosts in which to replicate, mutate, and potentially adapt further to human physiology.⁹

Spillover Dynamics in Non-Bovine Mammalian Populations

While domestic dairy cattle currently represent the largest mammalian reservoir in the ongoing outbreak, the 2.3.4.4b clade exhibits an unprecedented capacity to infect a highly diverse array of mammalian species. These spillover events occur primarily through direct physical contact with infected wild birds, scavenging on infected avian carcasses, or prolonged exposure to heavily contaminated agricultural environments.³⁰

Infection in Swine Populations and the Mixing Vessel Theory

The most alarming non-bovine mammalian detection occurred in late October 2024, when the United States Department of Agriculture confirmed the first domestic swine infections in the United States on a backyard farming operation in Crook County, Oregon.⁴ The non-commercial, mixed-species farm housed poultry and livestock that freely shared water sources, housing infrastructure, and feeding equipment. Following an acute outbreak of highly pathogenic avian influenza in the poultry flock, rigorous testing revealed that two of the five swine residing on the premises were concurrently infected with the D1.2 genotype of the virus.¹⁹

The infection of domestic swine is considered a critical, top-tier biosecurity concern by global epidemiologists. Physiologically, the respiratory tracts of pigs are uniquely structured; the epithelial cells lining their respiratory tracts possess both avian-type (alpha 2,3-linked) and human-type (alpha 2,6-linked) sialic acid receptors.¹² This dual receptor expression profile makes swine exceptionally susceptible to co-infection by both avian influenza viruses and seasonal human influenza viruses simultaneously. If a single pig is co-infected by both strains, the viruses can undergo rapid genetic reassortment within the host cells. In this scenario, the pig acts as a biological "mixing vessel" to produce a novel, hybrid virus that could possess the severe respiratory pathology of an avian virus combined with the high transmissibility of a human virus—the exact evolutionary mechanism that precipitated the devastating 2009 H1N1 global pandemic.¹²

While the swine in Oregon did not exhibit severe clinical signs of illness and the extracted viral loads were remarkably low, the event validated long-standing virological models regarding the inherent risks of backyard, multi-species farming interfaces where avian and mammalian populations co-mingle freely.⁴ The prompt euthanasia of the animals and implementation of strict quarantine measures successfully contained the event, but the detection remains a defining milestone in the current outbreak.¹²

Domestic Felines and Raw Milk Exposure

Domestic and feral felines have demonstrated extreme, acute susceptibility to the current strain of highly pathogenic avian influenza. Unlike cattle or swine, which often exhibit subclinical or mild symptoms, feline infections are frequently catastrophic, characterized by rapid-onset severe neurological symptoms, blindness, respiratory distress, and exceptionally high mortality rates.³¹

A highly illustrative and tragic cluster of cases occurred in Los Angeles County, California, between December 2024 and January 2025. During this period, 16 cats across five different households died following exposure to the virus.³¹ Thorough epidemiological tracing linked these fatal infections directly to the consumption of unpasteurized, raw cow's milk or raw pet food containing infected poultry or beef.³¹ The feline cases are epidemiologically significant as they serve as stark sentinel events for the severe biological dangers of raw milk consumption. Furthermore, while cats are generally considered dead-end hosts that do not efficiently transmit the virus onward to other species, the presence of highly concentrated viral loads in domestic pets drastically increases the risk of intimate, high-dose human exposure within the household setting.³³

Marine Mammals and Terrestrial Wildlife

The ecological reach of the virus extends deep into pristine wildlife populations. Routine surveillance and post-mortem examinations of deceased wildlife conducted by state and federal agencies have yielded positive virus detections across dozens of species. An unprecedented case occurred in Dixie County, Florida, where a deceased bottlenose dolphin was confirmed to be infected with the Eurasian H5 clade 2.3.4.4b virus.⁶ The dolphin exhibited extraordinarily high viral loads within its brain tissue, resulting in severe neurological lesions and meningoencephalitis.³⁶ Researchers hypothesize that the marine mammal contracted the virus through direct interaction with infected seabirds, marking one of the first known cetacean infections in North America and highlighting the profound, unprecedented disruption of coastal ecosystems by a primarily avian pathogen.⁶

Terrestrial surveillance up to February 2026 continues to detect the virus in diverse scavenging and predatory mammals. Federal databases record positive detections in red foxes, unidentified skunks, Catalina Island foxes, and house mice across states ranging from California to Connecticut and Montana.³⁷ Furthermore, the virus was detected for the first time in alpacas in May 2024 on a premises in the United States where infected poultry had recently been depopulated. This confirmed that camelids are also highly susceptible to the B3.13 bovine strain when environmental contamination is sufficiently high.³⁸

Table 2 provides a detailed snapshot of the diverse mammalian species impacted by the virus leading into early 2026.

Table 2: Representative Mammalian Detections of H5N1 in the United States (Late 2025 - Early 2026)

Species	Location	Date Detected	Epidemiological Context
Catalina Island Fox	Los Angeles, California	February 2026	Wildlife surveillance; fatal infection likely due to environmental exposure to diseased wild birds.37
Domestic Cat	Burlington, New Jersey	February 2026	Companion animal; potential raw milk consumption or direct wild bird exposure.37
Bottlenose Dolphin	Brevard, Florida	January 2026	Marine environment; high viral load in brain tissue, neurological infection via seabird interaction.36
House Mouse	Walker, Georgia	January 2026	Terrestrial rodent; serves as an indicator of severe environmental contamination on agricultural premises.37
Swine (Domestic)	Crook County, Oregon	October 2024	Backyard farm interface; shared water and housing with infected poultry, highlighting reassortment risk.4
Alpaca	United States	May 2024	Camelid susceptibility; infected by the B3.13 strain following poultry co-mingling.38

Human Epidemiology and Clinical Profiles

Despite the widespread, uncontrolled dissemination of the virus in multiple animal populations, confirmed human infections remain relatively rare. However, the frequency of human detection has increased concurrently with the massive agricultural outbreaks in dairy cattle and commercial poultry. Between February 2024 and February 2026, the United States reported a total of 71 confirmed human cases of avian influenza A(H5).⁷ The overwhelming majority of these cases are explicitly linked to direct, occupational exposure to infected animals or highly contaminated environments within the commercial agriculture sector.⁷

An exhaustive analysis of the exposure sources for the 71 documented cases reveals the following precise distribution: 41 cases were directly associated with exposure to infected dairy herds, 24 cases were linked to commercial poultry farms and mass culling operations, three cases were associated with other animal exposures (such as backyard flocks or wild birds), and the exposure source for three distinct cases remains entirely unknown.⁷ The cases with unknown exposure sources are of paramount concern to public health officials, as they may indicate unrecognized environmental reservoirs, asymptomatic human-to-human transmission, or brief, subclinical transmission chains that evade standard contact tracing efforts.¹⁵

Clinical Presentation and Mild Disease

The clinical presentation of human H5N1 infections in the current United States outbreak diverges slightly from historical global norms. Historically, H5N1 in humans—particularly in Asia and the Middle East—was characterized by severe, deep lower respiratory tract infections with extraordinarily high mortality rates often exceeding fifty percent.⁵ In the current United States outbreak, particularly among dairy workers exposed to the B3.13 genotype, the predominant and most frequently reported symptom has been acute conjunctivitis, presenting as severe eye redness, irritation, and tearing.³⁹

The frequent manifestation of conjunctivitis is likely intrinsically tied to the specific route of occupational exposure. Workers in commercial milking parlors are frequently subjected to splashes of raw, virus-laden milk directly into their eyes. The epithelial cells of the human eye contain receptors susceptible to avian influenza binding, facilitating localized infection.³⁹ Alongside conjunctivitis, patients generally report mild influenza-like illness, including mild fever, cough, sore throat, severe fatigue, and diffuse muscle aches.⁴¹ The illness typically resolves within a few days to two weeks with the prompt administration of antiviral medications such as oseltamivir, to which the currently circulating strains remain largely susceptible.¹³

Severe Morbidity and Mortality

While the statistical majority of cases have been classified as mild, the virus absolutely retains its biological capacity to cause catastrophic, life-threatening illness. Severe clinical disease is characterized by aggressive pneumonia, acute respiratory distress syndrome, sepsis, meningoencephalitis, and rapid multi-organ failure.⁴¹ As of February 2026, the ongoing outbreak has resulted in two confirmed human fatalities within the United States.⁷

The first recorded fatality occurred in Louisiana in January 2025. The patient, an individual over the age of 65 who suffered from underlying chronic health conditions, contracted a severe, rapidly progressing respiratory infection following documented exposure to a backyard flock and wild birds.⁴² Genomic sequencing of viral isolates recovered from the patient revealed infection with the D1.1 genotype, a strain closely related to those circulating in wild waterfowl and responsible for severe mass-mortality poultry outbreaks.⁴⁵ The case highlighted the heightened, acute vulnerability of older individuals and those with preexisting comorbidities to the severe physiological stress of avian influenza.⁴²

The second fatality occurred in Washington State in November 2025. The patient, who similarly suffered from underlying medical conditions, developed severe illness in late October, was hospitalized with rapidly deteriorating respiratory function in early November, and subsequently succumbed to the disease on November 21, 2025.⁴⁷ Strikingly, comprehensive laboratory sequencing verified that the infection was caused by an influenza A(H5N5) virus.⁴⁷ This event represented the first globally reported human case of the H5N5 subtype, underscoring the relentless, unpredictable reassortment of the virus in the wild and the profound danger posed by the resulting viral progeny.⁴⁷ Extensive epidemiological contact tracing following both fatalities yielded absolutely no evidence of human-to-human transmission, confirming that these were tragic, isolated spillover events.⁴⁴

Non-fatal but severe hospitalizations have also been documented. In February 2025, an adult male commercial poultry worker in Mercer County, Ohio, was hospitalized with severe respiratory and non-respiratory symptoms.¹³ The patient had endured prolonged, unprotected contact with deceased infected poultry during a mass culling operation. Initial upper respiratory tract swabs returned negative results; however, lower respiratory tract sampling ultimately confirmed deep infection with the D1.3 genotype.¹³ The delayed detection in this case highlights the clinical complexities of diagnosing avian influenza, as the virus often exhibits a preference for replicating deep within the pulmonary alveoli rather than the upper respiratory tract, requiring invasive sampling techniques for accurate diagnosis.¹³ The patient was eventually stabilized, discharged, and successfully recovered.⁴⁹

Table 3: Summary of United States Human A(H5) Cases (2024 - February 2026)

Exposure Source	Number of Cases	Primary Clinical Presentation	Epidemiological Notes
Dairy Cattle	41	Mild; predominant acute conjunctivitis, upper respiratory symptoms.	Associated predominantly with the B3.13 genotype in commercial farm workers exposed to raw milk.7
Commercial Poultry	24	Mild to Severe; conjunctivitis, severe lower respiratory distress.	Includes the hospitalized Ohio worker infected with the D1.3 genotype.7
Other Animal Exposure	3	Severe; acute respiratory distress syndrome, multi-organ failure.	Includes fatal cases in Louisiana (H5N1 D1.1) and Washington (H5N5) linked to backyard/wild bird exposure.7
Unknown Source	3	Variable symptomatology.	No definitive animal contact identified; subject to intensive, ongoing epidemiological investigation.7

Genetic Markers of Mammalian Adaptation in Humans

Viral isolates recovered from human cases are subjected to rigorous whole-genome sequencing to carefully monitor for adaptive mutations that could signal an increased pandemic threat. While the virus has not yet acquired the full, complex suite of genetic mutations necessary for efficient, sustained human-to-human airborne transmission, dangerous incremental adaptations are actively occurring.

For example, genetic sequencing of human isolates has identified the presence of the PB2 E627K mutation in a subset of patients.¹ This specific amino acid substitution is a well-documented, critical marker of mammalian adaptation. It functions to enhance viral replication efficiency at the lower temperatures typically found in the human upper respiratory tract, as opposed to the significantly warmer temperatures of the avian gastrointestinal tract.⁵² Furthermore, some human isolates have exhibited minor amino acid substitutions, such as NA-S247N, which in controlled laboratory settings demonstrate a slightly reduced susceptibility to neuraminidase inhibitors like oseltamivir.²¹ While these mutations do not currently render the virus untreatable, they serve as a stark biological warning that the virus is actively adapting to the selective pressures of the mammalian immune system and targeted antiviral therapeutics.²¹

Impact on Avian Populations and Commercial Agriculture

The devastating, systemic impact of the H5N1 clade 2.3.4.4b virus on its primary avian hosts cannot be overstated. Since the virus was first formally detected in commercial poultry in the United States in February 2022, it has precipitated the largest, longest, and most destructive animal health emergency in the history of the nation.⁸

The Commercial Poultry Sector and Mass Depopulation

As of early 2026, the virus has directly affected over 168 million commercial and backyard birds across all 50 states and Puerto Rico.³ The sheer scale of this epizootic dwarfs the previous record-breaking outbreak in 2014-2015, which resulted in the loss of 50.5 million birds over a highly condensed seven-month period.⁸ The extreme, uncompromising virulence of highly pathogenic avian influenza necessitates draconian agricultural control measures. Under current federal and state agricultural guidelines, the detection of a single infected bird on a commercial farm triggers the immediate, mandatory depopulation (culling) of the entire flock to prevent further environmental shedding and explosive viral spread.⁸

This systematic depopulation protocol has profoundly disrupted the agricultural supply chain. In states like Pennsylvania and Ohio, which serve as major national hubs for commercial egg and turkey production, individual localized outbreaks have necessitated the culling of millions of birds simultaneously.⁵⁴ In a single commercial egg-laying facility in Lancaster County, Pennsylvania, over 2.6 million hens were depopulated following a confirmed detection, alongside millions of other birds in surrounding facilities.⁵⁴ Similar catastrophic losses have occurred in Western Ohio, leading the state in total bird flu cases and severely impacting the nation's second-largest egg-producing region.⁵⁵

Economic Ramifications and Supply Chain Disruption

The economic toll of the ongoing agricultural crisis is staggering and multifaceted. By late 2024, the direct costs associated with the outbreak had exceeded 1.4 billion dollars.⁸ These massive expenditures primarily represent indemnity and compensation payments distributed by the United States Department of Agriculture to producers whose flocks were mandatorily culled, as well as the immense logistical costs of premises decontamination, biosecurity auditing, and carcass disposal.⁸

The severe disruption to the national egg-laying chicken inventory—which dropped significantly from historical baseline averages due to continuous, rolling culling operations—resulted in acute supply shortages and skyrocketing consumer prices for poultry products at the retail level.⁴⁵ Geographic price disparities became starkly evident, with states enacting stringent regulatory burdens experiencing retail egg price inflations significantly higher than the national average, heavily impacting consumer food security.⁵⁶

In direct response to the compounding economic and agricultural damage, the United States Department of Agriculture initiated a comprehensive 1 billion dollar emergency strategy in early 2025.⁵³ This multi-pronged federal approach is specifically designed to enhance "gold-standard" biosecurity infrastructure across both the poultry and dairy sectors, expedite financial relief funding to devastated farmers, and heavily invest in the aggressive research, development, and deployment of next-generation vaccines and therapeutics for livestock.⁵³

Wild Bird Reservoirs and Biodiversity Loss

The intractability of the current outbreak is fundamentally rooted in the virus's deep entrenchment within wild migratory bird populations. Unlike previous historical strains of highly pathogenic avian influenza that caused rapid, acute mortality in wild birds—thereby self-limiting their own geographic spread—the 2.3.4.4b clade possesses the unique ability to cause subclinical or asymptomatic infections in certain waterfowl species.³⁰ These asymptomatic carriers act as highly mobile, efficient reservoirs, shedding the virus continuously along vast continental flyways and continually re-seeding the pathogen into domestic agricultural environments during seasonal migrations.³⁰

Simultaneously, the virus has caused catastrophic mass-mortality events in other highly susceptible wild species, posing a severe, long-term threat to global biodiversity. Massive die-offs of raptors, scavenging birds, and coastal seabirds have been documented globally, with cascading ecological consequences that remain difficult to precisely quantify due to a pervasive lack of comprehensive, standardized wildlife monitoring.⁵⁸ The continuous environmental contamination generated by these infected wild populations ensures that domestic agriculture and local mammalian wildlife remain under constant, unyielding threat of viral exposure.

Table 4: Summary of Agricultural and Economic Impacts (2022 - Early 2026)

Metric	Quantifiable Impact	Contextual Details
Avian Depopulation	>168 Million Birds	Represents the total number of domestic commercial and backyard poultry culled to prevent viral transmission.3
Geographic Spread	50 States and Puerto Rico	Confirmed commercial or backyard flock detections recorded nationwide, indicating total saturation.8
Economic Cost	>$1.4 Billion	Direct federal costs related strictly to indemnification, mass culling, and rigorous sanitation by late 2024.8
Federal Response	$1 Billion Investment	Emergency USDA strategy launched to aggressively improve biosecurity, lower consumer food costs, and develop viable livestock vaccines.53

Public Health Surveillance and the One Health Response

The alarming transition of H5N1 from a strictly agricultural concern to a highly adaptable multi-species pathogen has necessitated a massive paradigm shift in public health monitoring. The traditional, siloed approaches separating human healthcare, veterinary medicine, and environmental science are critically insufficient to manage a complex virus that moves fluidly between these domains. Consequently, the national response in the United States has increasingly relied upon a "One Health" framework—a collaborative, multisectoral, and transdisciplinary approach that explicitly recognizes the intrinsic interconnectedness of human, animal, and environmental health.¹⁰

In early 2025, the Centers for Disease Control and Prevention, the United States Department of Agriculture, and the Department of the Interior jointly released the first-ever National One Health Framework to Address Zoonotic Diseases.¹¹ This formalized interagency cooperation facilitates the rapid sharing of sensitive genomic data, the alignment of environmental surveillance strategies, and the coordinated, rapid deployment of field epidemiological teams to novel outbreak epicenters.¹¹

Active Human Monitoring and Wastewater Surveillance

To mitigate the grave risk of an unrecognized human outbreak, the Centers for Disease Control and Prevention, operating in strict conjunction with state and local health departments, maintains an aggressive active monitoring program for individuals exposed to infected animals. Between February 2022 and January 2026, public health authorities continuously monitored over 31,900 exposed farm workers, veterinarians, and emergency cullers for a standard 10-day period following known exposure events.⁴¹ During this intensive monitoring timeframe, at least 1,300 individuals exhibiting compatible influenza-like symptoms were tested specifically for novel influenza A.⁴¹

In addition to targeted individual testing, public health officials rely heavily on broad environmental monitoring through the National Wastewater Surveillance System. Wastewater testing provides a highly valuable, unbiased, population-level indicator of viral shedding, capable of detecting the presence of the virus in a community even when human cases are exceptionally mild, subclinical, or actively avoiding medical care.⁴¹ Data collected from the system during the winter of 2025-2026 indicated relatively low levels of viral activity, with H5 genetic material detected in only 1.9 percent of monitoring sites nationwide during the week of mid-February 2026.⁶⁰ This environmental data aligns with the current clinical assessment that widespread, undetected human-to-human transmission is not currently occurring within the general population.⁴¹

Biosecurity and Preventative Therapeutics

The prevention of further human infection relies primarily on rigorous, unwavering occupational biosecurity. Public health agencies continue to issue stringent guidance requiring the use of full personal protective equipment—including N95 respirators, fluid-resistant coveralls, and specialized eye protection—for all personnel interacting with potentially infected livestock or participating in mass culling operations.³⁹

However, total compliance with these protocols in physically demanding agricultural settings remains a significant practical challenge. The persistent occurrence of conjunctivitis among dairy workers highlights the inherent difficulties of maintaining fog-free eye protection in hot, highly humid milking parlors. Consequently, there is a heightened medical emphasis on prophylactic and early therapeutic interventions. The Centers for Disease Control and Prevention maintains updated clinical guidance for healthcare providers, emphasizing the immediate empirical administration of antiviral treatments, such as oral oseltamivir, for any patient with suspected animal exposure and compatible symptoms, regardless of initial rapid diagnostic test results, which are notoriously unreliable for detecting novel strains.⁴¹

Simultaneously, the rapid development of efficacious vaccines for both animal and human populations remains a critical national security priority. The United States Department of Agriculture is currently fast-tracking the rigorous approval of field safety trials for multiple livestock vaccine candidates, aimed at eventually halting the viral replication cycle within dairy cattle and commercial poultry.¹⁹ On the human health front, federal agencies maintain a robust strategic stockpile of candidate vaccine viruses precisely matched to the currently circulating 2.3.4.4b clade, ensuring that mass pharmaceutical production could be rapidly initiated should the virus definitively acquire the genetic ability for sustained human-to-human transmission.⁴⁷

Conclusion

The current status of the H5N1 avian influenza outbreak in the United States represents an epidemiological scenario of profound complexity, persistent adaptation, and ongoing systemic risk. The virus, driven by the highly virulent and adaptable 2.3.4.4b clade, has successfully established a vast, interconnected multi-species reservoir that spans from wild migratory birds and marine ecosystems to domestic commercial agriculture. The unprecedented, sustained establishment of the virus within the national dairy herd, characterized by the dominant B3.13 genotype, and the subsequent dangerous spillovers of novel variants like D1.1 and D1.2 into cattle and domestic swine, signify that the pathogen is rapidly, successfully exploring new evolutionary space.

While the virus has caused catastrophic economic and biological damage to the commercial poultry sector and widespread morbidity in dairy cattle, the immediate physiological risk to the general human population remains relatively low. The 71 confirmed human cases documented through early 2026 predominantly feature mild clinical presentations linked to direct occupational exposure in agricultural settings. However, the occurrence of highly severe, fatal cases involving novel reassortants, such as the H5N5 detection in Washington State and the D1.1 fatality in Louisiana, serves as a stark, unavoidable reminder of the inherent lethality of these viruses when they successfully bypass human immunological defenses.

The successful detection of critical mammalian adaptation markers, including PB2 M631L and PB2 E627K, within circulating animal and human strains dictates that the virological barrier preventing a human pandemic is actively being eroded. The future trajectory of this unprecedented outbreak depends entirely upon the continued rigor and expansion of the One Health surveillance apparatus. Sustained federal investments in agricultural biosecurity, the aggressive maintenance of the National Milk Testing Strategy, vigilant, uninterrupted monitoring of viral genomics, and the rapid development of veterinary vaccines are not merely economic imperatives, but essential, foundational bulwarks against the emergence of the next global pandemic.

Works cited

1. Emerging H5N1 mutations (PB2-D701N, PB2-E627K, HA-S110N, NA-V116X) in a recent outbreak in U.S. dairy cows: need for continuous monitoring - PMC, accessed February 25, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC12333729/

2. Avian Influenza | U.S. Geological Survey - USGS.gov, accessed February 25, 2026, https://www.usgs.gov/centers/eesc/avian-influenza

3. H5N1 detections in US dairy cattle reach 1,000 - CIDRAP, accessed February 25, 2026, https://www.cidrap.umn.edu/avian-influenza-bird-flu/h5n1-detections-us-dairy-cattle-reach-1000

4. Federal and State Veterinary Agencies Share Update on HPAI Detections in Oregon Backyard Farm, Including First H5N1 Detections in Swine - usda aphis, accessed February 25, 2026, https://www.aphis.usda.gov/news/agency-announcements/federal-state-veterinary-agencies-share-update-hpai-detections-oregon

5. First H5 Bird Flu Death Reported in United States | CDC Newsroom, accessed February 25, 2026, https://www.cdc.gov/media/releases/2025/m0106-h5-birdflu-death.html

6. Report recounts Florida dolphin found with HPAIV - UF College of Veterinary Medicine, accessed February 25, 2026, https://www.vetmed.ufl.edu/2024/04/26/report-recounts-florida-dolphin-found-with-highly-pathogenic-avian-flu/

7. A(H5) Bird Flu: Current Situation - CDC, accessed February 25, 2026, https://www.cdc.gov/bird-flu/situation-summary/index.html

8. How Is Bird Flu Impacting Agriculture and Food Security in the United States? - CSIS, accessed February 25, 2026, https://www.csis.org/analysis/how-bird-flu-impacting-agriculture-and-food-security-united-states

9. Scientists show genetic change enabled bird flu to adapt to cattle and other mammals | News | The Pirbright Institute, accessed February 25, 2026, https://www.pirbright.ac.uk/news/scientists-show-genetic-change-enabled-bird-flu-adapt-cattle-and-other-mammals

10. Avian flu Q&A: U.S. updates, what to know and more - IDSA, accessed February 25, 2026, https://www.idsociety.org/science-speaks-blog/2025/avian-flu-qa-u.s.-updates-what-to-know-and-more

11. U.S. Government Releases First National One Health Plan to Protect People, Animals, and Our Environment from Shared Health Threats, accessed February 25, 2026, https://onehealthinitiative.com/u-s-government-releases-first-national-one-health-plan-to-protect-people-animals-and-our-environment-from-shared-health-threats/

12. U.S. Confirms First Cases of H5 Bird Flu Found in Pigs - Global Biodefense, accessed February 25, 2026, https://globalbiodefense.com/2024/11/06/u-s-confirms-first-cases-of-h5-bird-flu-found-in-pigs/

13. CDC confirms D1.3 genotype in recent H5N1 case in Ohio - CIDRAP, accessed February 25, 2026, https://www.cidrap.umn.edu/avian-influenza-bird-flu/cdc-confirms-d13-genotype-recent-h5n1-case-ohio

14. Highly Pathogenic Avian Influenza H5N1 Genotype B3.13 in Dairy Cattle: National Epidemiologic Brief - usda aphis, accessed February 25, 2026, https://www.aphis.usda.gov/sites/default/files/20240501-hpai-dairy-epi-brief.pdf

15. Human infections with highly pathogenic avian influenza A(H5N1) viruses in the United States from March 2024 to May 2025 - PMC, accessed February 25, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC12477757/

16. The potential of H5N1 viruses to adapt to bovine cells varies throughout evolution - PMC, accessed February 25, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC12706089/

17. Polymerase mutations underlie early adaptation of H5N1 influenza virus to dairy cattle and other mammals | bioRxiv, accessed February 25, 2026, https://www.biorxiv.org/content/10.1101/2025.01.06.631435v3.full-text

18. 2024 Highly Pathogenic Avian Influenza (H5N1) Livestock Event – Nevada and Arizona H5N1 D1.1 HPAI Dairy Investigation - usda aphis, accessed February 25, 2026, https://www.aphis.usda.gov/sites/default/files/20250611-epi-brief-nevada-arizona-h5n1-dairy.pdf

19. USDA Animal and Plant Health Inspection Service Shares Update on H5N1 Detection in Oregon Swine, Bovine Vaccine Candidate Progression, accessed February 25, 2026, https://www.aphis.usda.gov/news/agency-announcements/usda-animal-plant-health-inspection-service-shares-update-h5n1-detection

20. The Unexpected Battle Against Avian Flu in US Dairy | Choices Magazine Online, accessed February 25, 2026, https://www.choicesmagazine.org/choices-magazine/theme-articles/dairy-theme/the-unexpected-battle-against-avian-flu-in-us-dairy

21. Highly Pathogenic Avian Influenza Outbreak in the United States - GISAID, accessed February 25, 2026, https://gisaid.org/resources/gisaid-in-the-news/highly-pathogenic-avian-influenza-outbreak-in-the-united-states/

22. Federal testing improves detection of H5N1 avian flu in US dairy herds | CIDRAP, accessed February 25, 2026, https://www.cidrap.umn.edu/avian-influenza-bird-flu/federal-testing-improves-detection-h5n1-avian-flu-us-dairy-herds

23. Federal Testing Improves Detection of H5N1 Avian Flu in US Dairy Herds, accessed February 25, 2026, https://m.farms.com/news/federal-testing-improves-detection-of-h5n1-avian-flu-in-us-dairy-herds-238222.aspx

24. Federal testing improves detection of H5N1 avian flu in USA dairy herds – research finds, accessed February 25, 2026, https://dairybusinessmea.com/2026/02/07/federal-testing-improves-detection-of-h5n1-avian-flu-in-usa-dairy-herds-research-finds/

25. National Milk Testing Strategy | Animal and Plant Health Inspection Service - usda aphis, accessed February 25, 2026, https://www.aphis.usda.gov/livestock-poultry-disease/avian/avian-influenza/hpai-detections/livestock/nmts

26. Frequently Asked Questions: National Milk Testing Strategy - usda aphis, accessed February 25, 2026, https://www.aphis.usda.gov/livestock-poultry-disease/avian/avian-influenza/hpai-detections/livestock/nmts/faq

27. U.S. Department of Agriculture Announces 15 Additional States Onboard With National Milk Testing Strategy for H5N1, Shares Update on Vaccination Efforts, accessed February 25, 2026, https://www.usda.gov/about-usda/news/press-releases/2025/01/08/us-department-agriculture-announces-15-additional-states-onboard-national-milk-testing-strategy-h5n1

28. Fifteen more states enroll with USDA milk testing program - CIDRAP, accessed February 25, 2026, https://www.cidrap.umn.edu/avian-influenza-bird-flu/fifteen-more-states-enroll-usda-milk-testing-program

29. Investigation of Avian Influenza A (H5N1) Virus in Dairy Cattle | FDA, accessed February 25, 2026, https://www.fda.gov/food/alerts-advisories-safety-information/investigation-avian-influenza-h5n1-virus-dairy-cattle

30. Detections of Highly Pathogenic Avian Influenza in Wild Birds - usda aphis, accessed February 25, 2026, https://www.aphis.usda.gov/livestock-poultry-disease/avian/avian-influenza/hpai-detections/wild-birds

31. Avian Influenza (H5N1) | Veterinary Public Health | LAC DPH - LA County, accessed February 25, 2026, http://publichealth.lacounty.gov/vet/HPAI.htm

32. USDA Confirms 2nd Pig on Oregon Farm Tested Positive for H5N1 - Avian Flu Diary, accessed February 25, 2026, https://afludiary.blogspot.com/2024/11/usda-confirms-2nd-pig-on-oregon-farm.html

33. H5 Bird Flu: Information for Physicians | Acute Communicable Disease Control | Los Angeles County Public Health, accessed February 25, 2026, http://ph.lacounty.gov/acd/diseases/h5n1.htm

34. H5N1 Hpai – Resources & Guidance - usda aphis, accessed February 25, 2026, https://www.aphis.usda.gov/h5n1-hpai

35. A first: Avian influenza detected in American dolphin - UF College of Veterinary Medicine, accessed February 25, 2026, https://www.vetmed.ufl.edu/2022/09/07/a-first-avian-influenza-detected-in-american-dolphin/

36. Highly pathogenic avian influenza A(H5N1) virus in a common bottlenose dolphin (Tursiops truncatus) in Florida - PMC, accessed February 25, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC11026403/

37. Detections of Highly Pathogenic Avian Influenza in Mammals - usda aphis, accessed February 25, 2026, https://www.aphis.usda.gov/livestock-poultry-disease/avian/avian-influenza/hpai-detections/mammals

38. Highly Pathogenic Avian Influenza (HPAI) H5N1 Detections in Alpacas | Animal and Plant Health Inspection Service - usda aphis, accessed February 25, 2026, https://www.aphis.usda.gov/livestock-poultry-disease/avian/avian-influenza/hpai-detections/mammals/highly-pathogenic-avian

39. Novel H5N1 Bird Flu Outbreak - American Academy of Ophthalmology, accessed February 25, 2026, https://www.aao.org/education/bird-flu

40. Avian Influenza in 2025: Why This Moment Matters for Pandemic Preparedness | NETEC, accessed February 25, 2026, https://netec.org/2025/06/17/avian-influenza-in-2025-why-this-moment-matters-for-pandemic-preparedness/

41. A(H5) Bird Flu Surveillance and Human Monitoring | Bird Flu | CDC, accessed February 25, 2026, https://www.cdc.gov/bird-flu/h5-monitoring/index.html

42. H5N1: How worried should we be? - University of South Florida, accessed February 25, 2026, https://www.usf.edu/health/news/2025/h5n1-update.aspx

43. Louisiana reports first H5N1 bird flu death in U.S. | AHA News, accessed February 25, 2026, https://www.aha.org/news/headline/2025-01-07-louisiana-reports-first-h5n1-bird-flu-death-us

44. LDH reports first U.S. H5N1-related human death | Louisiana Department of Health, accessed February 25, 2026, https://ldh.la.gov/news/H5N1-death

45. USDA confirms new strain of avian flu in dairy cattle, accessed February 25, 2026, https://phhp.ufl.edu/2025/02/06/usda-confirms-new-strain-of-avian-flu-in-dairy-cattle/

46. Situation Report: First H5N1-Related Human Death in the U.S. - NETEC.org, accessed February 25, 2026, https://netec.org/2025/01/07/situation-report-first-h5n1-related-human-death-in-the-us/

47. Avian Influenza A(H5N5)- United States of America - World Health Organization (WHO), accessed February 25, 2026, https://www.who.int/emergencies/disease-outbreak-news/item/2025-DON590

48. Ohio Reports First Human Case of Bird Flu - Ohio Department of Health, accessed February 25, 2026, https://odh.ohio.gov/media-center/odh-news-releases/ohio-reports-first-human-case-of-bird-flu-021225

49. U.S. bird flu hospitalizations rise to 4 after Ohio discloses case - CBS News, accessed February 25, 2026, https://www.cbsnews.com/news/us-bird-flu-hospitalizations-rise-ohio-discloses-case/

50. Updated H5N1 Report: 70 Human Cases in the US as of April 2025 | Contagion Live, accessed February 25, 2026, https://www.contagionlive.com/view/updated-h5n1-report-70-human-cases-in-the-us-as-of-april-2025

51. Epidemiological Update Avian Influenza A(H5N1) in the Americas Region - Pan American Health Organization, accessed February 25, 2026, https://www.paho.org/sites/default/files/2025-01/2025-jan-24-phe-epiupdate-avian-influenza-eng-final.pdf

52. Avian influenza A (H5N1) virus in dairy cattle: origin, evolution, and cross-species transmission | mBio - ASM Journals, accessed February 25, 2026, https://journals.asm.org/doi/10.1128/mbio.02542-24

53. Nationwide Avian Flu Response Gains Momentum, Yet Urgent Action Remains Essential, accessed February 25, 2026, https://www.contagionlive.com/view/nationwide-avian-flu-response-gains-momentum-yet-urgent-action-remains-essential

54. Avian flu continues spread in Pennsylvania egg, turkey facilities, accessed February 25, 2026, https://www.cidrap.umn.edu/avian-influenza-bird-flu/avian-flu-continues-spread-pennsylvania-egg-turkey-facilities

55. Ohio leads the nation in bird flu cases. What's being done about it? | The Transmission, accessed February 25, 2026, https://www.unmc.edu/healthsecurity/transmission/2025/01/28/ohio-leads-the-nation-in-bird-flu-cases-whats-being-done-about-it/

56. USDA Invests Up To $1 Billion to Combat Avian Flu and Reduce Egg Prices, accessed February 25, 2026, https://www.usda.gov/about-usda/news/press-releases/2025/02/26/usda-invests-1-billion-combat-avian-flu-and-reduce-egg-prices

57. Bird Flu | Washington State Department of Agriculture, accessed February 25, 2026, https://agr.wa.gov/departments/animals-livestock-and-pets/avian-health/avian-influenza/bird-flu

58. New Jersey's Wild Bird Die-Off, accessed February 25, 2026, https://afludiary.blogspot.com/2026/02/new-jerseys-wild-bird-die-off.html

59. CDC A(H5N1) Bird Flu Response Update February 26, 2025, accessed February 25, 2026, https://www.cdc.gov/bird-flu/spotlights/h5n1-response-02262025.html

60. Wastewater Data for Avian Influenza A(H5) - CDC, accessed February 25, 2026, https://www.cdc.gov/nwss/rv/wwd-h5.html

61. CDC Activities and Accomplishments to Date in 2024—2025 H5 Bird Flu Response, accessed February 25, 2026, https://www.cdc.gov/bird-flu/spotlights/h5n1-response-01172025.html